Shannon Dahl

Shannon Dahl is an accomplished leader in the biotechnology sector with a focus on immunology and cell & gene therapy. As the Founder and Chief Executive Officer of Carve Bio since October 2021, Shannon leads a consulting firm that supports biotech companies through critical development phases. In addition to this role, Shannon serves as Chief Scientific Officer at Iolyx Therapeutics and holds strategic advisory positions at multiple organizations, including Radar Therapeutics, Laguna Bio, and Strand Therapeutics. Shannon's academic credentials include a Bachelor's degree in Materials Science and Engineering from the Massachusetts Institute of Technology and a Ph.D. in Biomedical Engineering from Duke University, complemented by corporate governance training from The George Washington University.